Hangzhou
China
Zhejiang Chinese Medical University
treatment-related adverse events, AE, triple-negative breast cancer, ICIs, programmed cell death-1/programmed cell death ligand 1, pembrolizumab
Salvia miltiorrhiza, TCP genes, ABA, tanshinones, phenolic acids, transcription factor